|
81
|
297
|
3tizA |
Cdk2 in complex with nsc 111848 |
|
78
|
298
|
3ti1A |
Cdk2 in complex with sunitinib |
|
81
|
297
|
3tiyA |
Cdk2 in complex with nsc 35676 |
|
86
|
298
|
3sw4A |
Crystal structure of the cdk2 in complex with thiazolylpyrimidine inhibitor |
|
84
|
298
|
3sqqA |
Cdk2 in complex with inhibitor rc-3-96 |
|
75
|
298
|
3s2pA |
Crystal structure of cdk2 with a 2-aminopyrimidine compound |
|
80
|
298
|
3rzbA |
Cdk2 in complex with inhibitor rc-2-23 |
|
86
|
298
|
3rprA |
Cdk2 in complex with inhibitor rc-2-49 |
|
82
|
298
|
3rpvA |
Cdk2 in complex with inhibitor rc-2-88 |
|
83
|
298
|
3rm6A |
Cdk2 in complex with inhibitor kvr-2-80 |
|
85
|
298
|
3royA |
Cdk2 in complex with inhibitor kvr-1-154 |
|
83
|
298
|
3rpoA |
Cdk2 in complex with inhibitor kvr-1-156 |
|
83
|
298
|
3rm7A |
Cdk2 in complex with inhibitor kvr-1-91 |
|
79
|
298
|
3rniA |
Cdk2 in complex with inhibitor rc-3-86 |
|
79
|
298
|
3rpyA |
Cdk2 in complex with inhibitor rc-2-40 |
|
79
|
298
|
3rmfA |
Cdk2 in complex with inhibitor rc-2-33 |
|
79
|
298
|
3r8mA |
Cdk2 in complex with inhibitor l3-3 |
|
77
|
298
|
3rk5A |
Cdk2 in complex with inhibitor rc-2-72 |
|
82
|
298
|
3r9oA |
Cdk2 in complex with inhibitor rc-2-143 |
|
78
|
298
|
3r9hA |
Cdk2 in complex with inhibitor rc-2-142 |
|
79
|
298
|
3r7iA |
Cdk2 in complex with inhibitor kvr-1-74 |
|
79
|
298
|
3ralA |
Cdk2 in complex with inhibitor rc-2-34 |
|
79
|
298
|
3rjcA |
Cdk2 in complex with inhibitor l4-12 |
|
88
|
298
|
3r9nA |
Cdk2 in complex with inhibitor rc-2-21 |
|
79
|
298
|
3r8uA |
Cdk2 in complex with inhibitor rc-1-132 |
|
78
|
298
|
3rkbA |
Cdk2 in complex with inhibitor rc-2-73 |
|
82
|
298
|
3rahA |
Cdk2 in complex with inhibitor rc-2-22 |
|
77
|
298
|
3r8lA |
Cdk2 in complex with inhibitor l3-4 |
|
94
|
355
|
3rgfA |
Crystal structure of human cdk8/cycc |
|
83
|
298
|
3r83A |
Cdk2 in complex with inhibitor kvr-2-92 |
|
79
|
298
|
3r7uA |
Cdk2 in complex with inhibitor kvr-1-75 |
|
83
|
298
|
3r7yA |
Cdk2 in complex with inhibitor kvr-2-88 |
|
87
|
298
|
3r8vA |
Cdk2 in complex with inhibitor rc-1-135 |
|
79
|
298
|
3rk9A |
Cdk2 in complex with inhibitor rc-2-74 |
|
78
|
298
|
3rakA |
Cdk2 in complex with inhibitor rc-2-32 |
|
76
|
298
|
3r8zA |
Cdk2 in complex with inhibitor rc-1-136 |
|
80
|
298
|
3r7vA |
Cdk2 in complex with inhibitor kvr-1-9 |
|
80
|
298
|
3r9dA |
Cdk2 in complex with inhibitor rc-2-135 |
|
79
|
298
|
3r7eA |
Cdk2 in complex with inhibitor kvr-1-67 |
|
83
|
298
|
3raiA |
Cdk2 in complex with inhibitor kvr-1-160 |
|
81
|
298
|
3r8pA |
Cdk2 in complex with inhibitor nsk-mc1-6 |
|
79
|
298
|
3rk7A |
Cdk2 in complex with inhibitor rc-2-71 |
|
83
|
298
|
2iw8A |
Structure of human thr160-phospho cdk2-cyclin a f82h-l83v-h84d mutant with an o6-cyclohexylmethylguanine inhibitor |
|
108
|
365
|
5xqxA |
Human cdk8-cycc in complex with compound 4: n-methyl-4-(4-pyridyl)-1h-pyrrole-2-carboxamide |
|
86
|
298
|
2iw9A |
Structure of human thr160-phospho cdk2-cyclin a complexed with a bisanilinopyrimidine inhibitor |
|
55
|
274
|
5uq3A |
Crystal structure of human cdk2-spy1-p27 ternary complex |
|
73
|
296
|
5uq2A |
Crystal structure of human cdk2-spy1 complex |
|
70
|
294
|
5uq1A |
Crystal structure of human cdk2-spy1 complex |
|
84
|
300
|
5osmA |
Cdk2(f80c, c177a) with covalent adduct at c80 |
|
83
|
293
|
5oo3A |
Cdk2(f80c, c177a) with covalent ligand at f80c |
